Showing 12,381 - 12,400 results of 34,997 for search '(( 50 ((ng decrease) OR (((we decrease) OR (a decrease)))) ) OR ( 5 point decrease ))', query time: 1.15s Refine Results
  1. 12381
  2. 12382
  3. 12383

    dPRPS plays a critical function during cellular response to oxidative stress. by Keemo Delos Santos (7349087)

    Published 2019
    “…<p>(A) Ovaries (upper panel) or fat bodies (lower panel) of adult <i>dPRPS GFP-trap</i> flies fed with PBS or PQT are immunostained for GFP (green) and DAPI (blue). …”
  4. 12384

    B[a]P treatment results in modulation of intracellular phosphop38 MAP kinase. by Kallol Dutta (215291)

    Published 2010
    “…Similarly, phosphoP38 MAP kinase level in 0.2 µM B[a]P treated group after 24 h, was significantly decreased as compared to that in 12 h post treatment group. …”
  5. 12385

    Impact of mepolizumab in patients with high-burden severe asthma within a managed care population by Njira L. Lugogo (13119569)

    Published 2023
    “…Of the 264 patients with ≥1 OCS claim during baseline, 191 (72.3%) showed a decrease in mean daily OCS use by ≥50% in 117 patients (61.3%). …”
  6. 12386

    A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia by Nagore I. Marín-Ramos (1600555)

    Published 2019
    “…In this work we report a potent ICMT inhibitor, compound <b>3</b> [UCM-1336, IC<sub>50</sub> = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras. …”
  7. 12387

    A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia by Nagore I. Marín-Ramos (1600555)

    Published 2019
    “…In this work we report a potent ICMT inhibitor, compound <b>3</b> [UCM-1336, IC<sub>50</sub> = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras. …”
  8. 12388

    A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia by Nagore I. Marín-Ramos (1600555)

    Published 2019
    “…In this work we report a potent ICMT inhibitor, compound <b>3</b> [UCM-1336, IC<sub>50</sub> = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras. …”
  9. 12389

    Trypacidin, a Spore-Borne Toxin from <em>Aspergillus fumigatus</em>, Is Cytotoxic to Lung Cells by Thierry Gauthier (185229)

    Published 2012
    “…Trypacidin was the most toxic, decreasing cell viability and triggering cell lysis, both effects occurring at an IC<sub>50</sub> close to 7 µM. …”
  10. 12390

    Raw data. by Changzhi Liu (518454)

    Published 2025
    “…This study aimed to explore the association between RC levels and the risk of vertebral fractures in a longitudinal cohort.</p><p>Methods</p><p>A total of 1995 participants aged 50 years or older who underwent chest computed tomography (CT) scans for lung cancer screening between July 2016 and December 2019 were included in this study. …”
  11. 12391
  12. 12392

    Baseline characteristics of the subjects. by Changzhi Liu (518454)

    Published 2025
    “…This study aimed to explore the association between RC levels and the risk of vertebral fractures in a longitudinal cohort.</p><p>Methods</p><p>A total of 1995 participants aged 50 years or older who underwent chest computed tomography (CT) scans for lung cancer screening between July 2016 and December 2019 were included in this study. …”
  13. 12393

    Knockdown of nr2f1a causes defects in zebrafish vascular development. by Bao-Jueng Wu (621818)

    Published 2014
    “…At the same stage ISVs are stalled at mid-somite in nr2f1a<sup>e2i2</sup> morphants (<b>D, F</b>). (<b>I</b>) Quantification of percentage of completed ISV shows a50% increase compared to <i>nr2f1a</i> morphants (n = 26 in wt and n = 34 in nr2f1aMO) at 30 hpf. …”
  14. 12394

    Parity and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Epidemiologic Studies by Hong-Bo Guan (464993)

    Published 2014
    “…</p><p>Conclusion</p><p>In summary, these findings suggest that higher parity is associated with a decreased risk of PC. Future large consortia or pooled studies are warranted to fully adjust for potential confounders to confirm this association.…”
  15. 12395
  16. 12396
  17. 12397
  18. 12398
  19. 12399
  20. 12400

    S2 Data - by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”